Diana Ernst, RPh

Most Recent Articles by Diana Ernst, RPh

FDA: New Med Guide for Patients Receiving Gadolinium-Based Contrast Agents

FDA: New Med Guide for Patients Receiving Gadolinium-Based Contrast Agents

By

These Medication Guides should be provided the first time an outpatient receives a GBCA injection at an MRI center; hospital patients are not required to receive a Medication Guide.

Lyrica Approved as Adjunctive Tx for Partial Onset Seizures in Children

Lyrica Approved as Adjunctive Tx for Partial Onset Seizures in Children

By

The approval was based on a 12-week, double-blind, placebo-controlled study (N=295) in pediatric patients 4-17 years of age.

Acadia Addresses Concerns Over Nuplazid Safety in Parkinson Disease Patients

Acadia Addresses Concerns Over Nuplazid Safety in Parkinson Disease Patients

By

Concerns over Nuplazid were initially voiced in a CNN article in early April which reported that the drug had been associated with over 700 deaths since its launch in March 2017.

FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction

FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction

By

Clinicians should conduct a medical evaluation as soon as suspicious symptoms are reported and discontinue lamotrigine if HLH is suspected.

AASM: Medical Marijuana Should Not Be Used to Treat Sleep Apnea

AASM: Medical Marijuana Should Not Be Used to Treat Sleep Apnea

By

Continuous positive airway pressure (CPAP) remains the mainstay of medical treatment for OSA.

More Articles by Diana Ernst, RPh

Sign Up for Free e-newsletters



CME Focus